3 High-Yield Dividend Stocks That Could Soar 22% to 49%, According to Wall Street

Motley Fool04-28

Pfizer has better prospects than meet the eye. Brookfield Infrastructure's asset rotation strategy should drive growth and higher distributions. Brookfield Renewable should benefit from ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2430031428?lang=en_US&edition=fundamental","thumbnail":"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F774353%2Fsolar-panels-with-engineers.jpg&op=resize&w=165&h=104","is_english":true,"pubTime":"2024-04-28 17:50","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2430031428","market":"us","top_or_hot":-1,"title":"3 High-Yield Dividend Stocks That Could Soar 22% to 49%, According to Wall Street","media":"Motley Fool","content":"<div>\n<p>Pfizer has better prospects than meet the eye.\n\n\n\n\n\n\n\nBrookfield Infrastructure's asset rotation strategy should drive growth and higher distributions.\n\n\n\n\n\n\n\nBrookfield Renewable should benefit from ...</p>\n\n<a href=\"https://www.fool.com/investing/2024/04/28/3-high-yield-dividend-stocks-that-could-soar-22-to/\">Source Link</a>\n\n</div>\n","source":"fool_stock","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 High-Yield Dividend Stocks That Could Soar 22% to 49%, According to Wall Street</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 High-Yield Dividend Stocks That Could Soar 22% to 49%, According to Wall Street\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-04-28 17:50 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2024/04/28/3-high-yield-dividend-stocks-that-could-soar-22-to/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Pfizer has better prospects than meet the eye.\n\n\n\n\n\n\n\nBrookfield Infrastructure's asset rotation strategy should drive growth and higher distributions.\n\n\n\n\n\n\n\nBrookfield Renewable should benefit from ...</p>\n\n<a href=\"https://www.fool.com/investing/2024/04/28/3-high-yield-dividend-stocks-that-could-soar-22-to/\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4133","symbol_name":"新能源发电业者","start_time":0,"source_url":"https://www.fool.com/investing/2024/04/28/3-high-yield-dividend-stocks-that-could-soar-22-to/","article_id":"2430031428","we_media_id":null,"thumbnails":["https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F774353%2Fsolar-panels-with-engineers.jpg&op=resize&w=165&h=104"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2430031428","pubTimestamp":1714297800,"sourceInfo":{"source_id":"fool_stock","name":"Motley Fool"},"weMediaInfo":null,"summary":"Whether or not these stocks hit analysts' price targets, they all should be attractive to investors seeking great income and solid growth.","collect":0,"end_time":0,"defaultTopTitle":"fool.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4133":"新能源发电业者","BK4581":"高盛持仓","BEP":"Brookfield Renewable Partners LP","BEPC":"Brookfield Renewable Corp.","IE00BLSP4239.USD":"Legg Mason ClearBridge - Tactical Dividend Income A Mdis USD Plus","SG9999013999.USD":"UOB UNITED GLOBAL HEALTHCARE FUND (USDHDG) INC","IE00BLSP4452.SGD":"Legg Mason ClearBridge - Tactical Dividend Income A Mdis SGD-H Plus","SG9999003800.SGD":"Nikko AM Global Dividend Equity Acc SGD-H","SG9999001176.SGD":"UOB UNITED GLOBAL HEALTHCARE \"SGD\" (ACC)","LU0456855351.SGD":"JPMorgan Funds - Global Equity A (acc) SGD","IE00B19Z3581.USD":"Legg Mason ClearBridge - Value A Acc USD","PFE":"辉瑞","LU1023059063.AUD":"BGF WORLD HEALTHSCIENCE \"A2\" (AUDHDG) ACC","BK4592":"伊斯兰概念","LU0289739699.SGD":"AB INTERNATIONAL HEALTH CARE PORTFOLIO \"A\" (SGD) ACC","LU1057294990.SGD":"Blackrock World Healthscience A2 SGD-H","IE00B19Z3B42.SGD":"Legg Mason ClearBridge - Value A Acc SGD","BK4534":"瑞士信贷持仓","BK4585":"ETF&股票定投概念","SG9999011175.SGD":"Nikko AM Global Dividend Equity Dis SGD-H","SG9999002232.USD":"Allianz Global High Payout USD","BK4533":"AQR资本管理(全球第二大对冲基金)","LU0234572021.USD":"高盛美国核心股票组合Acc","BK4007":"制药","SG9999002224.SGD":"Allianz Global High Payout SGD","LU0058720904.USD":"联博国际健康护理基金A","BK4568":"美国抗疫概念","LU1066051498.USD":"HSBC GIF GLOBAL EQUITY VOLATILITY FOCUSED \"AM2\" (USD) INC","BK4588":"碎股","BK4550":"红杉资本持仓","LU1066053197.SGD":"HSBC GIF GLOBAL EQUITY VOLATILITY FOCUSED \"AM3\" (SGDHDG) INC","LU0868494617.USD":"UBS (LUX) EQUITY SICAV - US TOTAL YIELD SUSTAINABLE \"P\" (USD) ACC","LU0122379950.USD":"贝莱德世界健康科学A2"},"translate_title":"据华尔街报道，3只高收益股息股票可能飙升22%至49%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"BEPC":1,"US10Y.BOND":1,"US12M.BOND":1,"US2Y.BOND":1,"US30Y.BOND":1,"US3Y.BOND":1,"US5Y.BOND":1,"US6M.BOND":1,"US7Y.BOND":1,"BEP":1,"PFE":0.9,"US912797GB79.BOND":0.6,"US912797GK78.BOND":0.6,"US912797GL51.BOND":0.6,"US912797GW17.BOND":0.6,"US912797HE00.BOND":0.6,"US912797HG57.BOND":0.6,"US912797FH58.BOND":0.6,"US912797HH31.BOND":0.6,"US912797FS14.BOND":0.6},"content_text":"Pfizer has better prospects than meet the eye.\n\n\n\n\n\n\n\nBrookfield Infrastructure's asset rotation strategy should drive growth and higher distributions.\n\n\n\n\n\n\n\nBrookfield Renewable should benefit from several tailwinds.\n\nIncome investors can be growth investors, too. Granted, it's not always easy to find stocks that pay generous dividends and offer solid prospects of share price appreciation. However, such stocks exist. Here are three high-yield dividend stocks that could soar 22% to 49% over the next 12 months, according to Wall Street.1. PfizerPfizer (PFE 0.55%) stock has been on a downward trajectory for nearly two and a half years. Blame it mainly on declining demand for the company's COVID-19 vaccine and oral antiviral drug Paxlovid. However, Pfizer also faces the looming loss of exclusivity for multiple products.Despite this bad news, analysts remain perhaps surprisingly bullish about Pfizer. The average analysts' 12-month price target reflects an upside potential of around 22%. Not everyone on Wall Street is enamored with Pfizer. One analyst surveyed by LSEG in April recommended selling the stock. But over half of the analysts polled rated Pfizer as a buy or a strong buy. I don't know if Pfizer will hit the 12-month price target. However, I agree with the overall optimism about the stock over the long run. The drugmaker's launches of new products should generate more than enough additional revenue to make up for the sales losses stemming from its patent cliff. Pfizer's wheeling and dealing should also pay off handsomely with promising new products added to its lineup thanks to shrewd acquisitions.The stock's valuation doesn't reflect Pfizer's better-than-meets-the-eye prospects. Pfizer's shares trade below 11.9 times forward earnings. By comparison, the forward earnings multiple for the S&P 500 healthcare sector is 18. Income investors should love Pfizer's juicy dividend yield of nearly 6.6%. I expect the company to continue increasing its dividend payout over the next several years.2. Brookfield InfrastructureBrookfield Infrastructure (BIP -0.80%) (BIPC -1.04%) is another high-yield stock that some investors seem to have given up on. Units of the limited partnership (LP) trading under the BIP ticker and shares of the corporate entity trading under the BIPC ticker are both down significantly over the last 12 months.Analysts haven't thrown in the towel on Brookfield Infrastructure, though. Seven of the nine analysts surveyed by LSEG in April rate the stock as a buy or strong buy. The consensus 12-month price target is roughly 39% higher than the current price. Will Brookfield Infrastructure jump that much? Maybe, maybe not. Wall Street is right to be upbeat about the stock overall, though, in my opinion.Brookfield Infrastructure owns a diversified portfolio of infrastructure assets, including utilities, rail, toll roads, terminals, pipelines, data centers, and cell towers. Its strategy of acquiring top assets, improving them, and selling mature assets to invest in new opportunities should enable the company to grow funds from operations (FFO) per unit by 10% or more annually. I like that Brookfield Infrastructure is committed to growing its distribution by 5% to 9% each year. That's especially great considering the LP's distribution yield tops 5.9% and the yield for BIPC is over 5.1%.3. Brookfield RenewableThere's another Brookfield that income investors and growth investors should find attractive. Brookfield Renewable (BEP 0.19%) (BEPC 0.09%) is a sibling of Brookfield Infrastructure: Brookfield Asset Management is the parent for both companies.Like Brookfield Infrastructure, Brookfield Renewable trades under two tickers -- one for its LP (BEP) and another for its corporate entity (BEPC). Analysts are especially enthusiastic about BEPC with the consensus 12-month price target reflecting an upside potential of 49%. As with the other stocks on the list, I'm uncertain if Brookfield Renewable will manage to hit Wall Street's price target. However, I'm on the same page as analysts about the company's long-term prospects.Brookfield Renewable owns hydroelectric, wind, solar, and distributed energy facilities across the world. The company expects to invest at least $7 billion in new renewable energy assets over the next five years. It should benefit from tailwinds including aggressive carbon emissions reduction targets and the increasing demand for electricity. This renewable energy leader has increased its distribution by a compound annual growth rate of 6% over the last 20 years. Brookfield Renewable intends to grow its distribution by 5% to 9% annually. With its yield currently topping 6%, this stock looks like a great pick for income investors who also seek growth.","kind":null,"is_publish_news":null,"is_publish_highlight":null,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2430031428"}